Medical Procedure News

RSS

Advances in yttrium-90 radioembolization for liver cancer

Finding innovative, minimally invasive ways to treat liver cancer-and being able to tailor that treatment individually to patients-are hallmarks of interventional radiologists. Advances in yttrium-90 (Y-90) radioembolization for liver cancer, a leading cause of cancer deaths worldwide, are reported in studies in the October Journal of Vascular and Interventional Radiology.

20 Oct 2011

BRA Day to promote awareness on breast reconstruction surgery

Only seven per cent of female breast cancer patients opt for breast reconstruction surgery. Dr. Melinda Musgrave is determined to find out why.

20 Oct 2011

CJC publishes paper on the timing of coronary stenting

The Canadian Journal of Cardiology has published a paper on the timing of coronary stenting, a thought-provoking paper that challenges one of the dogmas of acute heart attack management today.

20 Oct 2011

Breastfeeding during minor procedures mitigates pain in preterm neonates

Poorly managed pain in the neonatal intensive care unit has serious short- and long-term consequences, causing physiological and behavioral instability in preterm infants and long-term changes in their pain sensitivity, stress arousal systems, and developing brains. In a study published in the November issue of PAIN-, researchers report that breastfeeding during minor procedures mitigated pain in preterm neonates with mature breastfeeding behaviors.

19 Oct 2011

Comprehensive roadmap promises to improve cancer immunotherapy development

The Cancer Immunotherapy Consortium (CIC) of the Cancer Research Institute (CRI) and the Association for Cancer Immunotherapy (CIMT) have issued a joint white paper, published in the October 13 issue of Nature Biotechnology, outlining a comprehensive roadmap that promises to help improve and facilitate the path forward in the development of novel immunotherapies for cancer.

19 Oct 2011

Pioneer Pharma, Innocoll enter license and distribution agreement for CollaGUARD

Innocoll, Inc. announced it has entered into a License and Distribution Agreement with Pioneer Pharma in China for CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery.

19 Oct 2011

Multimodal analgesia is used less than 25% of the time prior to surgery

Many surgical patients are concerned about the level of pain they will experience. In a new study presented at ANESTHESIOLOGY 2011, researchers from Thomas Jefferson University identified that multimodal analgesia, a combination of pain medication and therapeutic measures to improve pain control, is used less than 25 percent of the time prior to surgery.

19 Oct 2011

PACBIS tool may help identify pre-surgical behaviors in parents, children

A clinical study presented at ANESTHESIOLOGY 2011 highlighted a behavioral assessment tool that may help anesthesia providers identify pre-surgical behaviors in parents and children that lead to maladaptive behaviors in children after surgery.

19 Oct 2011

AAGL to showcase innovative surgical approaches, teaching tools at 40th Global Congress

Technology has radically changed the way surgeons practice medicine, and nowhere is this more evident than in the field of gynecologic endoscopy. AAGL, the oldest professional organization devoted to teaching minimally invasive treatment for women's health problems, will showcase a number of innovative surgical approaches and teaching tools among the hundreds of postgraduate courses and practice labs offered at its annual Global Congress, November 6-11, 2011 at the Westin Diplomat in Hollywood, FL.

19 Oct 2011

African-Americans donate exclusively to family members for living kidney transplants

Family matters, especially when it comes to African-Americans and living kidney donation. In a study conducted at Wake Forest Baptist Medical Center, researchers found that African-Americans donate almost exclusively to family members for living kidney transplants, as compared to Caucasians.

19 Oct 2011

Electron-beam sterilized dialysis membrane may increase risk of thrombocytopenia

Patients who had undergone hemodialysis using dialyzers that had been sterilized with the use of electron beams were more likely to develop thrombocytopenia, according to a study in the October 19 issue of JAMA.

19 Oct 2011

UCSD unveils Center for the Future of Surgery

Every year, millions of patients undergo lifesaving surgeries. The outcome of each procedure is driven by dynamic factors such as the patient's health, drugs and instruments used, team communication, and the wisdom of the surgeon's hand. To advance safety and innovation in today's operating rooms, the School of Medicine at the University of California, San Diego has unveiled the Center for the Future of Surgery (CFoS) ─ the largest state-of-the art facility in the nation dedicated to catalyzing novel surgical technologies, techniques and teaching methods.

19 Oct 2011

Jersey Shore completes first procedure with Abiomed's Impella 2.5 heart pump

Jersey Shore University Medical Center announces the completion of its first procedure with Abiomed's Impella 2.5 heart pump. Jersey Shore is the first and only regional hospital to include the World's Smallest Heart Pump in their portfolio of treatment options to assist critically ill heart patients.

19 Oct 2011

Christie introduces hand-held version of VeinViewer

Christie Medical Holdings, Inc. today announced the market launch of the company's newest product, VeinViewer Flex. With the addition of this fifth-generation VeinViewer, following the recent launch of VeinViewer VisionXTND, Christie now provides a full portfolio of three product tiers that addresses the needs of every major health care market segment.

18 Oct 2011

FDA clears Spineology's Rampart line of Interbody fusion implants

Spineology Inc.,the innovator in anatomy-conserving spine surgery, announced today that it has received FDA clearance for, and is initiating launch of, the new Rampart™ line of Interbody fusion implants.

18 Oct 2011

BIOTRONIK introduces line extension to its popular 4 F compatible, self-expanding stent system

BIOTRONIK AG, a leading manufacturer of vascular interventional devices, announced the introduction of a line extension to its popular 4 F compatible, self-expanding stent system dedicated for the treatment of long disease segments in the superficial femoral artery (SFA) and infrapopliteal arteries.

18 Oct 2011